GalNAc (TEG)-CPG

GalNAc (TEG)-CPG

Catalog Number:
MRS1279038APT
Mfr. No.:
APT-0087-500/0087-1000
Price:
Inquiry
Size:
Quantity:
Add to Cart:
Add to Cart
    • Overview

      • GalNAc CPG allows the synthesis of siRNA-GalNAc conjugate.
        500Å and 1000Å are available.
        N-acetylgalactosamine (GalNAc) is a well-defined liver-targeted moiety benefiting from its high affinity with asialoglycoprotein receptor (ASGPR).
        By conjugating it directly to the oligonucleotides or decorating it to a certain delivery system as a targeting moiety, GalNAc has achieved compelling successes in the development of nucleic acid therapeutics.
        Other reagents for GalNAc conjugate technology are available under request.
        Product citations:
        Novel Cluster and Monomer-Based GalNAc Structures Induce Effective Uptake of siRNAs in Vitro and in Vivo

        Please contact us at for specific academic pricing.

        More Details

        GalNAc (TEG)-CPG
        GalNAc Conjugates for Hepatic Targeted Delivery of siRNA
    • Properties
      • Appearance
        Light yellow solid
        Other Properties
        Pore Size: 500/1000 Å
        Storage
        Store in the dark (Shelf Life: 2 years)

        * Research Use Only

We Also Recommend

4-Triazolyl Uridine CED phosphoramidite

4-Triazolyl Uridine CED phosphoramidite

Beta-L-2'-tBDSilyl Uridine 3'-lcaa CPG 1000A

Beta-L-2'-tBDSilyl Uridine 3'-lcaa CPG 1000A

Beta-L-2'-tBDSilyl Uridine 3'-CED phosphoramidite

Beta-L-2'-tBDSilyl Uridine 3'-CED phosphoramidite